Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

PRIVATE PLACEMENT FOR ACCREDITED INVESTORS--CBD BASED LIVER DISEASE DRUG

NASH Pharmaceuticals Inc. is developing novel therapies for patients diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatosis (NASH). The Company has an exclusive option to acquire the patent-pending technology developed at the Hebrew University of Jerusalem. A USPTO review of the patent is expected in late 2017.

NASH PHARMACEUTICALS INC is currently conducting a private placement targeted to accredited investors and qualified investors may connect Alfred Wong at:[e-mail] for more info.

linkedin.com/pulse/private-placement-accreditted-investors-cbd-based-liver-kal-malhi

Business Description

NASH PHARMACEUTICALS is developing strategic alliances with other universities around the world to acquire and develop novel technologies to treat fatty liver diseases... NASH Pharmaceuticals Inc. is developing novel therapies for patients diagnosed with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatosis (NASH). The Company has an exclusive option to acquire the patent-pending technology developed at the Hebrew University of Jerusalem. A USPTO review of the patent is expected in late 2017... We are on a mission to eradicate liver cirrhosis caused by fatty liver disease. We believe that with the advances in technology and the discovery of medicinal benefits of marijuana, a cure for this disease is just around the corner.

www.matchdeck.com/company-monitor/company/32585405-nash-pharmaceuticals/profile

What happened to the option to acquire a patent from Hebrew University of Jerusalem?

What was the outcome of USPTO review of said patent?

What's the patent number?

What happened to the CBD angle Nash Pharmaceuticals hyped up previously on it's website?

How does the CBD (marijuana) angle align with "repurposed" drugs for clinical trials?

Is the Private Placement from 2017 still ongoing?

How much money was raised?

Where did the money go?

Did Nash Pharmacueticals ever partner with other universities as stated in their mission?

There is simply too many unanswered questions surrounding Nash Pharmacueticals. I continue to believe their just a Paper Tiger. They have accomplished nothing to warrant taking over Breathtec.

Letting Nash Pharmacueticals get it's foot in the door of Breathtec will be dangerous move IMO. It's simply a money pit waiting to suck the life out of common shareholders like a tornado.

Nash Pharmacueticals is all over the place in terms of what/how they claim to pursue new drug treatments. Lots more questions are forthcoming.

/////AMG

P.S. As I stated in a previous post, they will eat thier young to find any marijuana angle to milk commoners dry. If ineffective, simply "repurpose" the mission.